India Active Pharmaceutical Ingredients Market, By Manufacturer, By Synthesis Type, By Drug Type, By Application, By Product Type, By Formulation

Description

India active pharmaceutical ingredients market is estimated to be valued at USD 13.72 Bn in 2024 and is expected to reach USD 23.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 13.72 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	7.70%	2031 Value Projection:	US$ 23.10 Bn

Figure. India Active Pharmaceutical Ingredients Market Share (%), By Manufacturer, 2024

India Active Pharmaceutical Ingredients Market - IMG1

India has established itself as a global sourcing hub for generic APIs due to availability of large pool of scientifically skilled professionals and a robust manufacturing infrastructure. Lower costs of production and strong process chemistry skills have enabled Indian pharmaceutical companies to gain market share in regulated markets. The country manufactures over 350 APIs across therapeutic areas including anti-retrovirals, anti-infectives, Cardiovascular, Anti-diabetics, and Oncology segments. Rising expenditures on healthcare and increasing demand for generic drugs can drive the market growth.

Market Dynamics:

India active pharmaceutical ingredients market growth is driven by rising availability of affordable treatment options due to a large domestic population base and rapidly growing exports. Strong process chemistry skills and lower costs enjoyed by domestic manufacturers compared to Western counterparts drives the market growth. However, stringent regulatory norms in overseas markets and environmental compliance issues can hamper the market growth. Moreover, dependence on imports for key starting materials limits self-reliance. Development of complex generics and novel drug delivery systems can offer opportunities in specialty/orphan drugs segments. Investments in R&D and upgradation of technological capabilities is crucial for companies to sustain leadership in long run.

Key Features of the Study:

This report provides in-depth analysis of the India active pharmaceutical ingredients market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the India active pharmaceutical ingredients market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Sun Pharmaceutical Industries, Lupin, Aurobindo Pharma, Dr. Reddy's Laboratories, Cipla

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

India active pharmaceutical ingredients market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the India active pharmaceutical ingredients market

Detailed Segmentation-

By Manufacturer
- Captive API
- Merchant API
By Synthesis Type
- Synthetic
- Biotech
By Drug Type
- Generic
- Branded
By Application
- Cardiology
- Oncology
- Pulmonology
- Neurology
- Orthopedic
- Ophthalmology
- Other
By Product Type
- Low Potent APIs
- High Potent APIs
By Formulation
- Oral
- Topical
- Parenteral
- Drops
- Others
Company Profiles:
- Reddy's Laboratories
- Aurobindo Pharma
- Lupin
- Cipla
- Sun Pharmaceutical Industries
- Cadila Healthcare
- Hetero Drugs
- Divis Laboratories
- Jubilant Pharmova
- Granules India
- Laurus Labs
- Aarti Drugs
- Alembic Pharmaceuticals
- Alkem Laboratories
- Biocon
- Glenmark Pharmaceuticals
- Ipca Laboratories
- Unichem Laboratories

Product Code: CMI4785

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Manufacturer
- Market Snapshot, By Synthesis Type
- Market Snapshot, By Drug Type
- Market Snapshot, By Application
- Market Snapshot, By Product Type
- Market Snapshot, By Formulation
- Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global India Active Pharmaceutical Ingredients Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global India Active Pharmaceutical Ingredients Market, By Manufacturer, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Captive API
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Merchant API
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global India Active Pharmaceutical Ingredients Market, By Synthesis Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Synthetic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Biotech
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global India Active Pharmaceutical Ingredients Market, By Drug Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Generic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Branded
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global India Active Pharmaceutical Ingredients Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Pulmonology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neurology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Orthopedic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ophthalmology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Other
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global India Active Pharmaceutical Ingredients Market, By Product Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Low Potent APIs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
High Potent APIs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

10. Global India Active Pharmaceutical Ingredients Market, By Formulation 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Topical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Parentral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Drops
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

11. Competitive Landscape

Company Profiles
- Dr. Reddy's Laboratories
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Aurobindo Pharma
- Lupin
- Cipla
- Sun Pharmaceutical Industries
- Cadila Healthcare
- Hetero Drugs
- Divis Laboratories
- Jubilant Pharmova
- Granules India
- Laurus Labs
- Aarti Drugs
- Alembic Pharmaceuticals
- Alkem Laboratories
- Biocon
- Glenmark Pharmaceuticals
- Ipca Laboratories
- Unichem Laboratories

12. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

13. References and Research Methodology

References
Research Methodology
About Us and Sales Contact